Paper
0
Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
Authors
Jenny Low,Cynthia Sung
Limin Wijaya,Yuan Wei,Abhay Rathore,Satoru Watanabe,Boon Tan,Liying Toh,Lian Chua,Yanan Hou,Angelia Chow,Shiqin Howe,Wing Chan,Kah Tan,Shimin Chung,Benjamin Cherng,David Lye,Paul Tambayah,Lee Ng,John Connolly,Martin Hibberd,Yee‐Sin Leo,Yin Cheung,Eng Ooi,Subhash Vasudevan,Yee Leo
+24 authors
,Sumio WatanabePublished
May 28, 2014
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.